FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385667080> ?p ?o ?g. }

• W4385667080 endingPage "e8686389" @default.
• W4385667080 startingPage "e8686389" @default.
• W4385667080 abstract "Topic: 20. Lymphoma Biology & Translational Research Background: The contribution of the tumor microenvironment (TME) to Peripheral T-Cell Lymphomas (PTCL) pathogenesis has been increasingly recognized. Despite recent advancements, current therapies are not adequately tailored to individual PTCL patients, and selecting treatments according to molecularly defined individuals is an unmet medical need. Patient-Derived-Xenografts (PDX) represent promising tools to model human cancer. Notably, PDX grow within a rich microenvironment, providing new opportunities to dissect the protumorigenic role of cancer niches. Aims: 1. Assess the potential of microenvironment-related signatures to predict PTCL prognosis; 2. Molecularly and functionally dissect the bidirectional crosstalk between lymphoma and stromal cells in PTCL; 3. Implement novel pre-clinical strategies for PTCL eradication. Methods: 362 primary PTCL samples were implanted to generate PDX representative of different PTCL subtypes. For the in vitro studies, PDX were digested to isolate tumor and stromal cells. Lymphoma cells viability, in co-culture or not with stromal cells, was detected with propidium iodide staining. Total RNA was extracted with TRIZOL and sequenced using the TruSeq-Stranded Total RNA sample preparation kit. We previously developed a bioinformatic pipeline for TME classification using RNA-sequencing data (Kotlov et al, 2021). For in-vivo experiments, tumors were implanted in NSG mice, and compounds were administered after engraftment. Tumor burden was evaluated by digital caliper or MRI. Results: First, we implemented a bioinformatic-based TME classification of 845 PTCL (including our and publicly available PTCL RNA sequences) and identified 4 major TME clusters. PTCL diagnoses were distributed across the 4 TME categories without any specific association. Interestingly, the “Th2-like” TME category was associated with a poor OS. We then applied this approach to PDX, finding the same 4 distinct TME categories. To functionally validate the TME role in TCL pathogenesis, stromal cells were isolated from PDX and incubated with freshly isolated PDX lymphoma cells. We demonstrated that the co-culture with matched stromal cells improved lymphoma survival. Transcriptionally, co-cultured stromal cells displayed the upregulation of signatures controlling biogenesis, migration, cell mobility, and DNA replication, closely mimicking the freshly isolated stromal cells. These signatures were partially lost when PDX-derived stromal cells were cultured alone. Then, we tested 40 drugs using a high-throughput flow cytometry-based co-culture platform to test whether stromal cells could modulate the therapeutic efficacy. The screens showed that stromal cells could significantly improve the lymphoma viability against selected compounds. Finally, we implemented in-vivo precision medicine-driven pre-clinical trials in PDX by integrating phenotypic, genomic and drug screening data. We envisioned combination protocols aiming either to debulk tumors and in parallel to eliminate the minimal residual disease protected in the cancer niche. Summary/Conclusion: These studies confirmed the relationship between lymphoma and microenvironmental cells. They pointed out distinct TME functional subgroups and the relevant role of stromal cells in the PTCL maintenance and therapeutic response. Our in vitro system provides a model for elucidating stromal:tumor cell interactions, allowing us to explore the pathogenetic mechanisms leading to drug resistance. We predict our data will propel patient-tailored curative strategies targeting tumor cells and the supporting niche.Keywords: T cell lymphoma, Microenvironment, Drug resistance, Mouse model" @default.
• W4385667080 created "2023-08-09" @default.
• W4385667080 creator A5006640724 @default.
• W4385667080 creator A5009431453 @default.
• W4385667080 creator A5010439379 @default.
• W4385667080 creator A5015073949 @default.
• W4385667080 creator A5015247283 @default.
• W4385667080 creator A5016042168 @default.
• W4385667080 creator A5017559600 @default.
• W4385667080 creator A5018114321 @default.
• W4385667080 creator A5026688095 @default.
• W4385667080 creator A5027244648 @default.
• W4385667080 creator A5031117270 @default.
• W4385667080 creator A5031563326 @default.
• W4385667080 creator A5031892664 @default.
• W4385667080 creator A5044173509 @default.
• W4385667080 creator A5044284041 @default.
• W4385667080 creator A5045672222 @default.
• W4385667080 creator A5045749988 @default.
• W4385667080 creator A5051684012 @default.
• W4385667080 creator A5056128255 @default.
• W4385667080 creator A5059389744 @default.
• W4385667080 creator A5064136350 @default.
• W4385667080 creator A5065256751 @default.
• W4385667080 creator A5069298336 @default.
• W4385667080 creator A5072909840 @default.
• W4385667080 creator A5090334093 @default.
• W4385667080 creator A5092614015 @default.
• W4385667080 date "2023-08-01" @default.
• W4385667080 modified "2023-10-17" @default.
• W4385667080 title "P1205: A LIVING PATIENT-DERIVED BIOREPOSITORY FOSTERING MICROENVIRONMENT DISSECTION IN T-CELL LYMPHOMA" @default.
• W4385667080 doi "https://doi.org/10.1097/01.hs9.0000971716.86863.89" @default.
• W4385667080 hasPublicationYear "2023" @default.
• W4385667080 type Work @default.
• W4385667080 citedByCount "0" @default.
• W4385667080 crossrefType "journal-article" @default.
• W4385667080 hasAuthorship W4385667080A5006640724 @default.
• W4385667080 hasAuthorship W4385667080A5009431453 @default.
• W4385667080 hasAuthorship W4385667080A5010439379 @default.
• W4385667080 hasAuthorship W4385667080A5015073949 @default.
• W4385667080 hasAuthorship W4385667080A5015247283 @default.
• W4385667080 hasAuthorship W4385667080A5016042168 @default.
• W4385667080 hasAuthorship W4385667080A5017559600 @default.
• W4385667080 hasAuthorship W4385667080A5018114321 @default.
• W4385667080 hasAuthorship W4385667080A5026688095 @default.
• W4385667080 hasAuthorship W4385667080A5027244648 @default.
• W4385667080 hasAuthorship W4385667080A5031117270 @default.
• W4385667080 hasAuthorship W4385667080A5031563326 @default.
• W4385667080 hasAuthorship W4385667080A5031892664 @default.
• W4385667080 hasAuthorship W4385667080A5044173509 @default.
• W4385667080 hasAuthorship W4385667080A5044284041 @default.
• W4385667080 hasAuthorship W4385667080A5045672222 @default.
• W4385667080 hasAuthorship W4385667080A5045749988 @default.
• W4385667080 hasAuthorship W4385667080A5051684012 @default.
• W4385667080 hasAuthorship W4385667080A5056128255 @default.
• W4385667080 hasAuthorship W4385667080A5059389744 @default.
• W4385667080 hasAuthorship W4385667080A5064136350 @default.
• W4385667080 hasAuthorship W4385667080A5065256751 @default.
• W4385667080 hasAuthorship W4385667080A5069298336 @default.
• W4385667080 hasAuthorship W4385667080A5072909840 @default.
• W4385667080 hasAuthorship W4385667080A5090334093 @default.
• W4385667080 hasAuthorship W4385667080A5092614015 @default.
• W4385667080 hasBestOaLocation W43856670801 @default.
• W4385667080 hasConcept C142724271 @default.
• W4385667080 hasConcept C16930146 @default.
• W4385667080 hasConcept C2776107976 @default.
• W4385667080 hasConcept C2779338263 @default.
• W4385667080 hasConcept C3020616263 @default.
• W4385667080 hasConcept C502942594 @default.
• W4385667080 hasConcept C71924100 @default.
• W4385667080 hasConcept C86803240 @default.
• W4385667080 hasConceptScore W4385667080C142724271 @default.
• W4385667080 hasConceptScore W4385667080C16930146 @default.
• W4385667080 hasConceptScore W4385667080C2776107976 @default.
• W4385667080 hasConceptScore W4385667080C2779338263 @default.
• W4385667080 hasConceptScore W4385667080C3020616263 @default.
• W4385667080 hasConceptScore W4385667080C502942594 @default.
• W4385667080 hasConceptScore W4385667080C71924100 @default.
• W4385667080 hasConceptScore W4385667080C86803240 @default.
• W4385667080 hasIssue "S3" @default.
• W4385667080 hasLocation W43856670801 @default.
• W4385667080 hasLocation W43856670802 @default.
• W4385667080 hasOpenAccess W4385667080 @default.
• W4385667080 hasPrimaryLocation W43856670801 @default.
• W4385667080 hasRelatedWork W2102442920 @default.
• W4385667080 hasRelatedWork W2191316874 @default.
• W4385667080 hasRelatedWork W2913171708 @default.
• W4385667080 hasRelatedWork W2925764871 @default.
• W4385667080 hasRelatedWork W3012628191 @default.
• W4385667080 hasRelatedWork W3102694858 @default.
• W4385667080 hasRelatedWork W3213906620 @default.
• W4385667080 hasRelatedWork W4205135539 @default.
• W4385667080 hasRelatedWork W4210924132 @default.
• W4385667080 hasRelatedWork W4285807049 @default.
• W4385667080 hasVolume "7" @default.
• W4385667080 isParatext "false" @default.
• W4385667080 isRetracted "false" @default.
• W4385667080 workType "article" @default.